Nicotrol, Nicoderm nicotine patches to be reviewed by NDAC for OTC marketing.
This article was originally published in The Tan Sheet
NICOTROL, NICODERM RX-TO-OTC SWITCHES TO BE REVIEWED BY NDAC on April 19 in a joint meeting with members of the Drug Abuse Advisory Committee. The two products will be the first smoking cessation patch switches to be considered for OTC use by the Nonprescription Drug Advisory Committee.
You may also be interested in...
Perrigo promotes in pricing, planning
Combe sells most of its OTC brands
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC